Periodontal radiographic alveolarbone loss determined by digital volume tomography in correlation with patient-specific risk factors and nutrition.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025827

Enrollment

163

Registered

2021-08-30

Start date

2021-06-24

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal alveolarbone loss

Interventions

Group 1: Retrospective examination of: - Radiographic Alveolarbone Loss

- Levels of 25-hydroxy vitamin D3 and LDL cholesterol, - DMFT, - Rheumatic diseases, - smoking, - statine-intake

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Available Cone-Beam CT of the alveolar bone between 01.01.2018 and 31.12.2020; Blood-sample (LDL-cholesterol-level, 25-Hydroxy Vitamin D3-level); minimum of 16 teeth

Exclusion criteria

Exclusion criteria: less than 16 teeth

Design outcomes

Primary

Measure	Time frame
Radiographic Alveolarbone Loss at 6 measurement points per tooth in a cone-beam-CT made for implant-prosthetic treatment planning using the "CoPeriodontiX" software (Dental Wings, Montreal, Canada).	—

Secondary

Measure	Time frame
Levels of 25-hydroxy vitamin D3 and LDL cholesterol, DMFT, Rheumatic diseases, smoking, statine-intake	—

Countries

Germany

Contacts

Public ContactKonstantin Johannes Scholz

Poliklinik für Zahnerhaltung und Parodontologie, Universitätsklinikum Regensburg

Konstantin.Scholz@ukr.de09419446024

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026